Evidence map›Paper›PMID 25309817›Full record

ArticleJournal of genetic syndromes & gene therapy2012

The Need for Gene Therapy for the Effective Treatment of Hemophilia.

Tung Wynn, William B Slayton, Roland W Herzog

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of genetic syndromes & gene therapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tung WynnDepartment of Pediatrics, Division of Hematology/Oncology, University of Florida, USA.
William B SlaytonDepartment of Pediatrics, Division of Hematology/Oncology, University of Florida, USA.
Roland W HerzogDepartment of Pediatrics, Division of Microbiology and Molecular Genetics, University of Florida, USA.

Funding

Vector CoreP01HL078810 · NHLBI · WISTAR INSTITUTE · PI ERTL, HILDEGUND C. J. · 2005 to 2014
$16.7M
Immunology of Factor IX Gene Transfer to LiverR01AI051390 · NIAID · UNIVERSITY OF FLORIDA · PI HERZOG, ROLAND W. · 2002 to 2022
$6.7M
Next Generation of Recombinant AAV Serotype Vectors for Gene TherapyR01HL097088 · NHLBI · UNIVERSITY OF FLORIDA · PI GAO, GUANGPING, HERZOG, ROLAND W. · 2010 to 2018
$5.4M
Oral Therapy for Hemophilia AR01HL109442 · NHLBI · UNIVERSITY OF FLORIDA · PI DANIELL, HENRY, HERZOG, ROLAND W. · 2011 to 2015
$3.5M
NHLBI NIH HHS P01 HL078810NHLBI NIH HHS R01 HL097088NHLBI NIH HHS R01 HL109442NIAID NIH HHS R01 AI051390
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID25309817
PMCPMC4190611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.